查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728429

照護現場診斷脂質檢測市場規模、佔有率和趨勢分析報告：按產品、應用、適應症、最終用途、地區和細分市場進行預測，2025 年至 2030 年

Point Of Care Lipid Test Market Size, Share & Trends Analysis Report By Product, By Application, By Disease Indication, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

照護現場脂質檢測市場的成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，全球照護現場脂質檢測市場預計到 2030 年將達到 11 億美元，預測期內的複合年成長率為 6.5%。

心血管疾病、糖尿病和腎臟疾病等慢性疾病的盛行率上升是推動市場成長的主要因素，這些疾病通常需要頻繁監測脂質才能有效管理。心血管併發症仍然是腎臟病患者的主要擔憂，其中脂質水平升高和全身性發炎等因素會增加風險。

此外，這一趨勢與預防性醫療保健的廣泛重視相吻合，早期發現脂質失衡有助於降低長期健康風險。攜帶式檢測設備可以在診所、醫院和家庭中提供即時結果，簡化患者護理並使個人能夠主動管理自己的健康。將這些工具與數位平台結合可以實現遠端監控，這在疫情期間獲得了發展勢頭，並且繼續有效地減少不必要的臨床就診。

照護現場脂質檢測市場報告重點

  • 耗材在產品領域佔據主導地位，佔 2024 年 61.9% 的最大收入佔有率。這是由快速且易於使用的測試程序對一次性耗材的需求所推動的。
  • 預計預測期內該設備的複合年成長率為 6.6%。這是因為現代分析設備的準確性、移動性和連接性特性有所提高，使其非常適合分散的情況。
  • 2024年，高血脂症佔據了最大的收入佔有率，為46.9%。這主要是由於對糖尿病和心血管疾病等慢性疾病的快速有效管理的需求日益成長。
  • 由於檢測技術的快速發展，提高了速度和可及性，預計預測期內高三酸甘油脂血症的複合年成長率為 7.0%。
  • 脂質和脂蛋白疾病將佔據市場主導地位，到 2024 年將佔據最大的收益佔有率，達到 38.7%。預計 2025 年至 2030 年間動脈粥狀硬化的發生率將以顯著的複合年成長率成長。
  • 醫院部門在市場中佔據主導地位，佔據 2024 年 32.2% 的最大收益佔有率。醫院需要快速、準確的脂質檢測，以便正確診斷和管理慢性病並改善患者的治療效果。
  • 北美將主導全球照護現場脂質檢測市場，到 2024 年將佔據 43.6% 的最大收益佔有率。這主要是因為將就地檢驗納入遠端醫療平台可以提高易用性和病人參與。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 全球照護現場脂質檢測市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球照護現場脂質檢測市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析

第4章全球照護現場脂質檢測市場：產品業務分析

  • 產品細分儀表板
  • 照護現場脂質檢測市場：產品差異分析
  • 2018-2030年全球照護現場脂質檢測市場規模及產品趨勢分析
  • 裝置
  • 耗材

5. 全球照護現場脂質檢測市場：應用業務分析

  • 應用程式細分儀表板
  • 照護現場脂質檢測市場：應用趨勢分析
  • 全球照護現場脂質檢測市場規模及應用趨勢分析（2018-2030）
  • 高血脂症
  • 高三酸甘油脂血症
  • 丹吉爾病
  • 高脂蛋白血症
  • 遺傳性高膽固醇症
  • 其他

6. 全球照護現場脂質檢測市場：適應症業務分析

  • 指示細分儀表板
  • 照護現場脂質檢測市場：適應症變化分析
  • 全球照護現場脂質檢測市場規模及趨勢分析（按適應症，2018-2030）
  • 脂質和脂蛋白疾病
  • 動脈硬化
  • 肝臟和腎臟疾病
  • 糖尿病
  • 其他

7. 全球照護現場脂質檢測市場：最終用途業務分析

  • 最終用途細分儀表板
  • 照護現場脂質檢測市場：最終用途變異分析
  • 2018-2030年全球照護現場脂質檢測市場規模及趨勢分析（依最終用途）
  • 醫院
  • 診所
  • 研究和診斷實驗室
  • 其他

8. 全球照護現場脂質檢測市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 全球照護現場脂質檢測市場（按地區）: 關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • Key Company Heat Map Analysis, 2024
  • 公司簡介
    • Callegari
    • Abbott Laboratories
    • MiCoBio
    • Nova Biomedical Corporation
    • VivaChek Biotech（Hangzhou）Co., Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Menarini Group
    • SD Biosensor, Inc e
Product Code: 978-1-68038-750-6

Point Of Care Lipid Test Market Growth & Trends:

The global point of care lipid test market is anticipated to reach USD 1.1 billion by 2030 and is anticipated to expand at a CAGR of 6.5% over the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of chronic conditions like cardiovascular diseases, diabetes, and kidney disorders is a key driver contributing to the market growth, as these conditions often necessitate frequent lipid monitoring for effective management. Cardiovascular complications remain a major concern for patients with kidney disease, where factors such as elevated lipid levels and systemic inflammation increase risks.

Furthermore, this trend aligns with the broader emphasis on preventive healthcare, where early detection of lipid imbalances helps mitigate long-term health risks. Portable testing devices enable real-time results at clinics, hospitals, or homes, streamlining patient care and empowering individuals to manage their health proactively. The integration of these tools with digital platforms supports remote monitoring, a practice that gained momentum during the pandemic and remains relevant for reducing unnecessary clinical visits.

Point Of Care Lipid Test Market Report Highlights:

  • Consumables dominated the product segment and accounted for the largest revenue share of 61.9% in 2024. This is attributed to the need for disposable and single-use consumables for rapid, user-friendly testing procedures.
  • Instruments are expected to grow at a CAGR of 6.6% over the forecast period, owing to contemporary analyzers' improved accuracy, mobility, and connectivity features, which make them perfect for decentralized situations.
  • The hyperlipidemia held the largest revenue share of 46.9% in 2024, primarily driven by the rising necessity for quick, effective management of chronic diseases such as diabetes and cardiovascular disease.
  • Hypertriglyceridemia is expected to grow at a CAGR of 7.0% over the forecast period, owing to the rapid developments in testing technologies that improve speed and accessibility.
  • Lipid and lipoprotein disorders dominated the market, with the largest revenue share of 38.7% in 2024. Atherosclerosis is expected to grow at a significant CAGR from 2025 to 2030.
  • The hospitals segment held the dominant position in the market and accounted for the largest revenue share, 32.2%, in 2024. Hospitals need quick, precise lipid testing to allow appropriate diagnosis and management of chronic situations, enhancing patient outcomes.
  • North America dominated the global point-of-care lipid test market and accounted for the largest revenue share of 43.6% in 2024, primarily due to the incorporation of point-of-care testing with telehealth platforms, which improves user-friendliness and patient engagement.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. Disease Indication
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Disease Indication Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Point of Care Lipid Test Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Point of Care Lipid Test Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Point of Care Lipid Test Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Point of Care Lipid Test Market: Product Movement Analysis
  • 4.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Consumables
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Point of Care Lipid Test Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Point of Care Lipid Test Market: Application Movement Analysis
  • 5.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
  • 5.4. Hyperlipidemia
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Hypertriglyceridemia
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Tangier Disease
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Hyperlipoproteinemia
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Familial Hypercholesterolemia
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Point of Care Lipid Test Market: Disease Indication Business Analysis

  • 6.1. Disease Indication Segment Dashboard
  • 6.2. Point of Care Lipid Test Market: Disease Indication Movement Analysis
  • 6.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By Disease Indication, 2018 to 2030 (USD Million)
  • 6.4. Lipid and Lipoprotein Disorders
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Atherosclerosis
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Liver and Renal Diseases
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Diabetes Mellitus
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Point of Care Lipid Test Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Point of Care Lipid Test Market: End Use Movement Analysis
  • 7.3. Global Point of Care Lipid Test Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinics
    • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Research and Diagnostic Laboratories
    • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Global Point of Care Lipid Test Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. Global Point of Care Lipid Test Market by Regional: Key Takeaways
  • 8.4. North America
    • 8.4.1. U.S.
      • 8.4.1.1. Key Country Dynamics
      • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.1.3. Competitive Scenario
      • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Canada
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.2.3. Competitive Scenario
      • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Mexico
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Germany
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.1.3. Competitive Scenario
      • 8.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.2.3. Competitive Scenario
      • 8.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.3. France
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Italy
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Spain
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Denmark
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.6.3. Competitive Scenario
      • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.7.3. Competitive Scenario
      • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Norway
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 8.5.8.3. Competitive Scenario
      • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.1.3. Competitive Scenario
      • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.2. China
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.2.3. Competitive Scenario
      • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.3. India
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Australia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Thailand
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key Country Dynamics
      • 8.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.1.3. Competitive Scenario
      • 8.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Argentina
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.7.2.3. Competitive Scenario
      • 8.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. South Africa
      • 8.8.1.1. Key Country Dynamics
      • 8.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.1.3. Competitive Scenario
      • 8.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.2.3. Competitive Scenario
      • 8.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.3. UAE
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.3.3. Competitive Scenario
      • 8.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 8.8.4. Kuwait
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 8.8.4.3. Competitive Scenario
      • 8.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key Company Heat Map Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Callegari
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Abbott Laboratories
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. MiCoBio
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Nova Biomedical Corporation
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. VivaChek Biotech (Hangzhou) Co., Ltd.
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. F. Hoffmann-La Roche Ltd.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Menarini Group
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. SD Biosensor, Inc e
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Abbreviations
  • Table 2. Global Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 3. Global Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 4. Global Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 5. Global Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. Global Point of Care Lipid Test Market, By Region, 2018 - 2030 (USD Million)
  • Table 7. North America Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
  • Table 8. North America Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. North America Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 10. North America Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 11. North America Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12. U.S. Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 13. U.S. Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 14. U.S. Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 15. U.S. Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. Canada Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 17. Canada Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 18. Canada Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 19. Canada Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. Mexico Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 21. Mexico Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 22. Mexico Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 23. Mexico Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. Europe Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
  • Table 25. Europe Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Europe Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 27. Europe Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 28. Europe Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29. Germany Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. Germany Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 31. Germany Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 32. Germany Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33. UK Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 34. UK Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 35. UK Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 36. UK Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. France Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 38. France Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 39. France Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 40. France Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Italy Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 42. Italy Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 43. Italy Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 44. Italy Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. Spain Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 46. Spain Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 47. Spain Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 48. Spain Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 49. Denmark Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 50. Denmark Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 51. Denmark Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 52. Denmark Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 53. Sweden Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 54. Sweden Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 55. Sweden Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 56. Sweden Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57. Norway Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 58. Norway Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 59. Norway Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 60. Norway Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Asia Pacific Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66. China Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 67. China Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 68. China Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 69. China Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 70. Japan Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 71. Japan Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 72. Japan Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 73. Japan Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 74. India Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 75. India Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 76. India Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 77. India Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78. South Korea Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 79. South Korea Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 80. South Korea Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 81. South Korea Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82. Australia Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 83. Australia Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 84. Australia Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 85. Australia Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86. Thailand Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 87. Thailand Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 88. Thailand Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 89. Thailand Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 90. Latin America Point of Care Lipid Test Market, By Country, 2018 - 2030 (USD Million)
  • Table 91. Latin America Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 92. Latin America Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 93. Latin America Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 94. Latin America Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 95. Brazil Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 96. Brazil Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 97. Brazil Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 98. Argentina Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 99. Argentina Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 100. Argentina Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 101. Argentina Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 102. MEA Point of Care Lipid Test Market, By Region, 2018 - 2030 (USD Million)
  • Table 103. MEA Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 104. MEA Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 105. MEA Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 106. MEA Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 107. South Africa Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 108. South Africa Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 109. South Africa Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 110. South Africa Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 111. Saudi Arabia Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 112. Saudi Arabia Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115. UAE Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 116. UAE Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 117. UAE Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 118. UAE Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)
  • Table 119. Kuwait Point of Care Lipid Test Market, By Product, 2018 - 2030 (USD Million)
  • Table 120. Kuwait Point of Care Lipid Test Market, By Application, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Point of Care Lipid Test Market, By Disease Indication, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Point of Care Lipid Test Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Point of Care Lipid Test Market: Market Outlook
  • Fig. 10 Point of Care Lipid Test Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Point of Care Lipid Test Market Driver Impact
  • Fig. 16 Point of Care Lipid Test Market Restraint Impact
  • Fig. 17 Point of Care Lipid Test Market Strategic Initiatives Analysis
  • Fig. 18 Point of Care Lipid Test Market: Product Movement Analysis
  • Fig. 19 Point of Care Lipid Test Market: Product Outlook and Key Takeaways
  • Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Consumables Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Point of Care Lipid Test Market: Application Movement Analysis
  • Fig. 23 Point of Care Lipid Test Market: Application Outlook and Key Takeaways
  • Fig. 24 Hyperlipidemia Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 Hypertriglyceridemia Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Tangier Disease Indication Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Hyperlipoproteinemia Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Familial Hypercholesterolemia Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 Point of Care Lipid Test Market: Disease Indication Movement Analysis
  • Fig. 31 Point of Care Lipid Test Market: Disease Indication Outlook and Key Takeaways
  • Fig. 32 Lipid and Lipoprotein Disorders Market Estimates and Forecasts, 2018 - 2030
  • Fig. 33 Atherosclerosis Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Liver and Renal Diseases Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Diabetes Mellitus Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Point of Care Lipid Test Market: End Use Movement Analysis
  • Fig. 38 Point of Care Lipid Test Market: End Use Outlook and Key Takeaways
  • Fig. 39 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Clinics Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Research and Diagnostic Laboratories Market Estimates and Forecasts, 2018 - 2030
  • Fig. 42 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 Global Point of Care Lipid Test Market: Regional Movement Analysis
  • Fig. 44 Global Point of Care Lipid Test Market: Regional Outlook and Key Takeaways
  • Fig. 45 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 71 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 72 Kuwait Market Estimates and Forecasts, 2018 - 2030